Infectious Disease Diagnostic Markets

Publication Date	August 2009
Publisher	Kalorama Information
Product Type	Report
Pages	180
ISBN Number	not applicable
Product Code	KAL00176

Buy this product or for assistance call +44 20 7060 7474

PDF £2,105.00$3501 | €2356

FAX Order above formats by FAX

Summary

The ubiquity of infections makes thier detection a healthcare priority and an ongoing opportunity for IVD companies. The aging of the population, and emerging threats - MRSA, swine flu, and others have had an impact on this market recently and will continue to in years to come. Kalorama Information has been observing diagnostic markets for over a decade and has assembled in this report, Infectious Disease Diagnostics, Kalorama Information has assembled its best primary and secondary research. This report focuses on products used for the diagnosis of bacterial and viral infections. The major consideration is given to bacterial infections because (a) they are the most frequent type of infections, and (b) the practical aspects of diagnosis and therapy are more meaningful based both on medial considerations and on market considerations. On the other hand, viral infections are becoming of greater importance due to (a) the discovery of new viral infections, (b) advances in the development of viral therapeutics, and (c) the mutation viruses that cause drug resistance.

Included in this report:

Market Size and Forecast for (Immunoassays, Rapid, DNA, ID/MIC )
Overview of Key Infections and Their Impact on the Market
Long-Term (10 Year) Trend in the Infectious Disease Diagnostics Market
Seven Conclusions and Recommendations
Key Product Summary: Immunoassay Products, Molecular Diagnostic Products, Amplification Products
Discussion and Listing of 'Home Brew' Products
Discussion of Leading Competitors in the Market
Increasing Use of Non Traditional Technologies in ID (FISH, Flow Cytometry, etc.)
The Role of NAT Testing Near-Term and Long-Term
A Glossary of Important Terms
Best Opportunities for IVD Companies

Market analysis in this report considers primarily the epidemiological considerations and the sizes patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis.

As with most Kalorama reports, this is a work of both market description and analysis, along with recommendations. The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, research scientists, business development managers and marketing managers.
In this report global (world) revenue numbers are presented based on reported and estimated manufacturer revenue.

Content

CHAPTER ONE: EXECUTIVE SUMMARY
- Overview
- Scope and Methodology
- Market Considerations
- Trends Affecting Infectious Disease Diagnosis Applications
- Opportunity for Diagnostic Products in Infectious Disease
- Drug Resistance
- Have Immunoassays Peaked?
- Need for Faster Tests
- Controlled Growthof NAT
- Drug Susceptibility and Resistance Testing Markets
- A Need for Simplification
CHAPTER TWO: OVERVIEW OF INFECTIOUS DISEASES
- General
- Infectivity
- Primary Pathogens
- Zoonoses
- Opportunistic Pathogens
- Disease Susceptibility
- Bacterial Infections
- Criteria
- Viral Infections
- Viral Drug Resistance
- Swine Flu and the IVD Industry
- Origin of Flu Virus Mixes
- PCR Test Development
- Late-Breaking Research Developments
- Use of Rapid Tests in Current Epidemic
CHAPTER THREE: TECHNOLOGY AND PRODUCTS
- Bacterial Cultures: Diagnosis and Susceptibility
- Blood Culture
- Throat Culture
- Sputum Cultures
- Spinal Fluid Cultures
- Stool Cultures
- Urine Cultures
- Viral Culture
- Immunoassays
- Agglutination Immunoassays
- Nephelometry
- Indirect Immunofluorescence
- Enzyme Immunoassay (ELISA, EIA)
- Fluorescence and Luminescence Immunoassay
- Magnetic Immunoassay
- Molecular Diagnostics
- Amplification Technologies
- Probe Technologies
CHAPTER FOUR: INFECTIOUS DISEASE DIAGNOSTICS MARKETS
- Increasing Use of Non-Traditional Systems
- FISH
- Cell Counting by Flow Cytometry
- Laser Based Microbial Detection
- Market Analysis
- Microbial Identification and Antimicrobial Sensitivity Tests
- Rapid Tests
- Immunoassays - Lab based
- STDs
- Supplies
- Competition
- Probe Technology
- Key Company Synopses
- AdvanDx
- Beckman Coulter
- bioMerieux
- BioRad -
- Cepheid -
- Gen-Probe
- Roche Molecular Diagnostics
- Siemens Healthcare Diagnostics -
CHAPTER FIVE: CONCLUSIONS AND STRATEGIC IMPLICATIONS
- First Conclusion
- Second Conclusion
- Third Conclusion
- Fourth Conclusion
- Fifth Conclusion
- Sixth Conclusion
- Seventh Conclusion
- GLOSSARY
- LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY:
- List of Figures
- Figure 1-1: Worldwide Infectious Disease Diagnostics Sales
- Figure 1-2: Trend in Revenue in Infectious Disease Diagnostics Long-Term (NAT, Rapid, Immunoassays)
CHAPTER TWO: OVERVIEW OF INFECTIOUS DISEASES
- List of Tables
- Table 2-1: Classification of Common Pathogenic Bacteria
- Table 2-2: Common Mechanisms of Antibacterial Resistance
CHAPTER THREE: TECHNOLOGY AND PRODUCTS
- List of Tables
- Table 3-1: Key Immunoassay Products Used for Clinical Testing for Bacterial Infections
- Table 3-2: Molecular Diagnostics Technologies
- Table 3-3: Gene Amplification Technologies
- Table 3-4: Commonly Used Signal Amplification Technologies for Genetic Analysis
- Table 3-5: Key Molecular Assay Products for the Diagnosis of Infectious Diseases (Company, Analyte, Test Category, Product, Technology)
- Table 3-6: Key Home BrewMolecular Assays for Infectious Diseases
CHAPTER FOUR: INFECTIOUS DISEASE DIAGNOSTICS MARKETS
- List of Tables
- Table 4-1: Companies Engaged in the Market for Bacterial Culture Products
- Table 4-1: PCR, FISH, Flow and Cell Imaging Systems for Bacteria / Virus Detection, 2008 and 2012 ($million)
- Table 4-2: Worldwide Microbiology/Virology Sales by Type (Immunoassays, Rapid, DNA, ID/MIC ) 2008-2013
- Table 4-3 : ID/MIC Revenue Breakdown (Automated Panels and Reagents, Manual Panels and Reagents, Blood Culture, Rapid Micro) and Supplies
- Table 4-4: Selected Chromogenic Growth Media (Company, Location, Media)